UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
life sciences & biomedicine (33) 33
science & technology (33) 33
humans (25) 25
female (19) 19
cardiovascular system & cardiology (18) 18
male (17) 17
middle aged (17) 17
aged (16) 16
cardiac & cardiovascular systems (16) 16
abridged index medicus (15) 15
risk factors (12) 12
treatment outcome (9) 9
analysis (8) 8
care and treatment (8) 8
double-blind method (8) 8
atrial fibrillation (7) 7
health aspects (7) 7
peripheral vascular disease (7) 7
cardiovascular disease (6) 6
dosage and administration (6) 6
follow-up studies (6) 6
obesity (6) 6
prevention (6) 6
stroke (6) 6
ticagrelor (6) 6
adenosine - analogs & derivatives (5) 5
adult (5) 5
clinical trials (5) 5
general & internal medicine (5) 5
heart attacks (5) 5
heart failure (5) 5
hemorrhage - chemically induced (5) 5
internal medicine (5) 5
myocardial infarction (5) 5
myocardial infarction - drug therapy (5) 5
research (5) 5
usage (5) 5
adenosine - administration & dosage (4) 4
adenosine - adverse effects (4) 4
aged, 80 and over (4) 4
anticholesteremic agents - therapeutic use (4) 4
biological and medical sciences (4) 4
body mass index (4) 4
cardiac patients (4) 4
cardiovascular diseases (4) 4
coronary artery disease (4) 4
diabetes (4) 4
drug therapy (4) 4
exercise (4) 4
heart attack (4) 4
medicine, general & internal (4) 4
physical activity (4) 4
proprotein convertase 9 - antagonists & inhibitors (4) 4
purinergic p2y receptor antagonists - administration & dosage (4) 4
secondary prevention (4) 4
time factors (4) 4
warfarin (4) 4
acute coronary syndromes (3) 3
antibodies, monoclonal - adverse effects (3) 3
antibodies, monoclonal - therapeutic use (3) 3
anticholesteremic agents - adverse effects (3) 3
anticoagulants (3) 3
behavior (3) 3
beverages (3) 3
cardiology (3) 3
cardiovascular diseases - prevention & control (3) 3
child (3) 3
cholesterol, ldl - blood (3) 3
confidence intervals (3) 3
dapagliflozin (3) 3
diet (3) 3
disease progression (3) 3
drug administration schedule (3) 3
health behavior (3) 3
health promotion (3) 3
heart diseases (3) 3
hospitalization (3) 3
medical colleges (3) 3
mortality (3) 3
myocardial infarction - blood (3) 3
myocardial infarction - mortality (3) 3
myocardial infarction - prevention & control (3) 3
purinergic p2y receptor antagonists - adverse effects (3) 3
pyridines - adverse effects (3) 3
stroke - prevention & control (3) 3
type 2 diabetes (3) 3
adenosine - pharmacokinetics (2) 2
alzheimer disease - cerebrospinal fluid (2) 2
alzheimer's disease (2) 2
amyloid (2) 2
arteriosclerosis (2) 2
aspirin (2) 2
atrial fibrillation - complications (2) 2
biochemistry & molecular biology (2) 2
biomarkers - blood (2) 2
blood glucose - metabolism (2) 2
blood platelets - drug effects (2) 2
body weight (2) 2
cardiac and cardiovascular systems (2) 2
cardiovascular (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2019, Volume 380, Issue 4, pp. 347 - 357
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Cardiovascular Diseases - etiology | Sodium-Glucose Transporter 2 Inhibitors - therapeutic use | Sodium-Glucose Transporter 2 Inhibitors - adverse effects | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Benzhydryl Compounds - adverse effects | Cardiovascular Diseases - mortality | Female | Glucosides - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Benzhydryl Compounds - therapeutic use | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Glucosides - adverse effects | Type 2 diabetes | Safety and security measures | Dapagliflozin | Dosage and administration | Drug therapy | Cardiovascular diseases | Risk factors | Heart failure | Myocardial infarction | Cerebral infarction | End-stage renal disease | Heart attacks | Mortality | Diabetes mellitus | Cardiovascular disease | FDA approval | Patients | Glomerular filtration rate | Heart rate | Ischemia | Sodium | Arteriosclerosis | Ketoacidosis | Death | Diabetes | Kidney diseases | Safety | Diabetes mellitus (non-insulin dependent) | Heart diseases | Index Medicus | Abridged Index Medicus | Life Sciences | Food and Nutrition | Animal biology | Cellular Biology | Pharmaceutical sciences | Cardiovascular Diseases | drug therapy | Benzhydryl Compounds | complications | Sodium-Glucose Transporter 2 Inhibitors | Hospitalization | prevention & control | Klinisk medicin | Diabetes Mellitus | etiology | Clinical Medicine | epidemiology | statistics & numerical data | adverse effects | mortality | Type 2 | Heart Failure | therapeutic use | Glucosides
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 2016, Volume 67, Issue 10, pp. 1145 - 1154
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2017, Volume 376, Issue 18, pp. 1713 - 1722
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 04/2016, Volume 315, Issue 15, pp. 1591 - 1599
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2016, Volume 67, Issue 23, pp. 2719 - 2728
peripheral arterial disease | ticagrelor | major adverse cardiovascular events | major adverse limb events | acute limb ischemia | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Myocardial Infarction - epidemiology | Purinergic P2Y Receptor Antagonists - administration & dosage | Vascular Grafting - statistics & numerical data | Humans | Middle Aged | Male | Secondary Prevention | Ischemia - prevention & control | Aspirin - administration & dosage | Dose-Response Relationship, Drug | Purinergic P2Y Receptor Antagonists - adverse effects | Adenosine - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Female | Stroke - epidemiology | Lower Extremity - surgery | Drug Therapy, Combination | Stroke - prevention & control | Hemorrhage - epidemiology | Ischemia - epidemiology | Adenosine - administration & dosage | Peripheral Arterial Disease - epidemiology | Adenosine - analogs & derivatives | Ischemia - surgery | Aged | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Lower Extremity - blood supply | Prevention | Medical colleges | Care and treatment | Ischemia | Cardiology | Heart attack | Heart failure | Anticoagulants | Aspirin | Stroke | Heart attacks | Heart surgery | Mortality | Cardiovascular disease | Confidence intervals | Disease prevention | Coronary vessels | Amputation | Chronic obstructive pulmonary disease | Diabetes | Index Medicus | Abridged Index Medicus | Kardiologi | Cardiac and Cardiovascular Systems | acute limb ischemia; major adverse cardiovascular events; major adverse limb events; peripheral arterial disease; ticagrelor
Journal Article